Poliomyelitis and Post-poliomyelitis Syndrome

  • Kanokwan Boonyapisit


Poliomyelitis and the post-poliomyelitis syndrome are often evaluated and cared for by neuromuscular specialists and in neuromuscular clinics. This chapter covers the etiology and pathogenesis, clinical manifestations, diagnosis, evaluation, and management of these disorders.


Poliomyelitis post-polio syndrome 


  1. 1.
    Kidd D, Williams AJ, Howard RS. Classical diseases revisited-poliomyelitis. Postgrad Med J. 1996;72:641–7.PubMedCrossRefGoogle Scholar
  2. 2.
    Howard RS. Poliomyelitis and the postpolio syndrome. BMJ. 2005;330:1314–9.PubMedCrossRefGoogle Scholar
  3. 3.
    Cohen JI. Enteroviruses and reoviruses. In: Fauci AS, Braunwald E, Kasper DL, Hauser SL, editors. Harrison’s principles of internal medicine. 17th ed. New York: McGraw Hill; 2008. p. 1208–13.Google Scholar
  4. 4.
    Racaniello VR. One hundred years of poliovirus pathogenesis. Virology. 2006;344:9–16.PubMedCrossRefGoogle Scholar
  5. 5.
    Heyman DL, Aylward RB. Eradicating polio. N Engl J Med. 2004;351:1275–7.CrossRefGoogle Scholar
  6. 6.
    Poliomyelitis-eradication initiative’s wider lessons. Lancet. 2004;363:93.Google Scholar
  7. 7.
    Dutta A. Epidemiology of poliomyelitis-options and update. Vaccine. 2008;26:5767–73.PubMedCrossRefGoogle Scholar
  8. 8.
    Centers for Disease Control and Prevention. Progress toward poliomyelitis eradication – Afghanistan and Pakistan, January 2010-September 2011. MMWR Morb Mortal Wkly Rep. 2011;60:1523–7.Google Scholar
  9. 9.
    Nkowane BM, Wassilak SGF, Orenstein WA. Vaccine associated paralytic poliomyelitis: United States: 1973 through 1984. JAMA. 1987;257:1335.PubMedCrossRefGoogle Scholar
  10. 10.
    MacLennan CA, Huissoon AP, Kumararatne DS. Vaccine-derived poliomyelitis 12 years after infection. N Engl J Med. 2011;364:2316–23.CrossRefGoogle Scholar
  11. 11.
    Kew OM, Sutter RW, de Gourville EM, Dowdle WR, Pallansch MA. Vaccine-derived polioviruses and the endgame strategy for global polio eradication. Annu Rev Microbiol. 2005;59:587–635.PubMedCrossRefGoogle Scholar
  12. 12.
    Zaoutis T, Klein JD. Enterovirus infections. Pediatr Rev. 1998;19:183–91.PubMedCrossRefGoogle Scholar
  13. 13.
    Rothbart HA. Enteroviral infections of the central nervous system. Clin Infect Dis. 1995;20:971–81.CrossRefGoogle Scholar
  14. 14.
    Solomon T, Willison HJ. Infectious causes of acute flaccid paralysis. Curr Opin Infect Dis. 2003;16:375–81.PubMedCrossRefGoogle Scholar
  15. 15.
    Marx A, Glass JD, Sutter RW. Differential diagnosis of acute flaccid paralysis and its role in poliomyelitis surveillance. Epidemiol Rev. 2000;22:298–316.PubMedCrossRefGoogle Scholar
  16. 16.
    Ooi MH, Wong SC, Lewthwaite P, Cardosa MJ, Solomon T. Clinical features, diagnosis, and management of enterovirus 71. Lancet Neurol. 2010;9:1097–105.PubMedCrossRefGoogle Scholar
  17. 17.
    Sejvar JJ. West Nile virus and ‘poliomyelitis’. Neurology. 2004;63:206–7.PubMedCrossRefGoogle Scholar
  18. 18.
    David WS, Doyle JJ. Acute infantile weakness: a case of vaccine-associated poliomyelitis. Muscle Nerve. 1997;20:747–9.PubMedCrossRefGoogle Scholar
  19. 19.
    Salk D. Eradication of poliomyelitis in the United States. I. Live virus vaccine-associated and wild poliovirus disease. Rev Infect Dis. 1980;2:228–42.PubMedCrossRefGoogle Scholar
  20. 20.
    Salk D. Eradication of poliomyelitis in the United States. II. Experience with killed poliovirus vaccine. Rev Infect Dis. 1980;2:243–57.PubMedCrossRefGoogle Scholar
  21. 21.
    Salk D. Eradication of poliomyelitis in the United States. III. Poliovaccines– practical considerations. Rev Infect Dis. 1980;2:258–73.PubMedCrossRefGoogle Scholar
  22. 22.
    Faden H. Poliovirus vaccination: a trilogy. J Infect Dis. 1993;168:25–8.PubMedCrossRefGoogle Scholar
  23. 23.
    Foege WH. Eradication of polio in Americas. JAMA. 1993;270:1857.CrossRefGoogle Scholar
  24. 24.
    Nathanson N, Kew OM. From emergence to eradication: the epidemiology of poliomyelitis deconstructed. Am J Epidemiol. 2010;172:1213–29.PubMedCrossRefGoogle Scholar
  25. 25.
    Strebel PM, Sutter RW, Cochi SL, et al. Epidemiology of poliomyelitis in the United States one decade after the last reported case of indigenous wild virus-associated disease. Clin Infect Dis. 1992;14:568–79.PubMedCrossRefGoogle Scholar
  26. 26.
    Centers for Disease Control and Prevention (CDC). Progress toward interruption of wild poliovirus transmission – worldwide, January 2010-March 2011. MMWR Morb Mortal Wkly Rep. 2011;60:582–6.Google Scholar
  27. 27.
    Centers for Disease Control and Prevention (CDC). Update on vaccine-derived polioviruses – worldwide, January 2008-June 2009. MMWR Morb Mortal Wkly Rep. 2009;58:1002–6.Google Scholar
  28. 28.
    Pallansch MA, Sandhu HS. The eradication of polio – progress and challenges. N Engl J Med. 2006;355:2508–11.PubMedCrossRefGoogle Scholar
  29. 29.
    Alexander LN, Seward JF, Santibanez TA, et al. Vaccine policy changes and epidemiology of poliomyelitis in the United States. JAMA. 2004;292:1696–701.PubMedCrossRefGoogle Scholar
  30. 30.
    Chumakov K, Ehrenfeld E. New generation of inactivated poliovirus vaccines for universal immunization after eradication of poliomyelitis. Clin Infect Dis. 2008;47:1587–92.PubMedCrossRefGoogle Scholar
  31. 31.
    American Academy of Pediatrics Committee on Infectious Diseases. Poliovirus. Pediatrics. 2011;128:805–8.CrossRefGoogle Scholar
  32. 32.
    Halstead LS, Rossi CD. Post-polio syndrome: clinical experience with 132 consecutive outpatients. In: Halstead LS, Weichers DO, editors. Research and clinical aspects of the late effects of poliomyelitis. White Plains: March of Dimes; 1987. p. 13–26.Google Scholar
  33. 33.
    Codd MB, Mulder DW, Kurland LT, Beard CM, O’Fallon WM. Poliomyelitis in Rochester, Minnesota, 1935–1955: epidemiology and long-term sequelae. A preliminary report. In: Halstead LS, Wiechers DO, editors. Late effects of poliomyelitis. Miami: Symposia Foundation; 1985. p. 121–34.Google Scholar
  34. 34.
    Jubelt B, Cashman NR. Neurological manifestations of the post-polio syndrome. Crit Rev Neurobiol. 1987;3:199–220.PubMedGoogle Scholar
  35. 35.
    Trojan DA, Cashman NR. Post-poliomyelitis syndrome. Muscle Nerve. 2005;31:6–19.PubMedCrossRefGoogle Scholar
  36. 36.
    Dalakas MC, Elder G, Hallett M, Ravits J, Baker M, Papadopoulos N, et al. A long-term follow-up study of patients with post-poliomyelitis neuromuscular symptoms. N Engl J Med. 1986;314:959–63.PubMedCrossRefGoogle Scholar
  37. 37.
    Howard RS, Wiles CM, Spencer GT. The late sequelae of poliomyelitis. Q J Med. 1988;251:219–32.Google Scholar
  38. 38.
    Kidd D, Howard RS, Williams AJ, Heatley FW, Panayiotopoulos CP, Spencer GT. Late functional deterioration following paralytic poliomyelitis. Q J Med. 1997;90:189–96.CrossRefGoogle Scholar
  39. 39.
    Jubelt B, Agre JC. Characteristics and management of post-polio syndrome. JAMA. 2000;284:412–4.PubMedCrossRefGoogle Scholar
  40. 40.
    Howard R. Late post-polio deterioration. Pract Neurol. 2003;3:66–77.CrossRefGoogle Scholar
  41. 41.
    Speier JL, Owen RR, Knapp M, Canine JK. Occurrence of post-polio sequelae in an epidemic population. In: Halstead LS, Weichers DO, editors. Research and clinical aspects of the late effects of poliomyelitis. White Plains: March of Dimes; 1987. p. 39–48.Google Scholar
  42. 42.
    Windebank AJ, Daube JR, Litchy WJ, et al. Late sequelae of paralytic poliomyelitis in Olmsted County, Minnesota. In: Halstead LS, Wiechers DO, editors. Research and clinical aspects of the late effects of poliomyelitis. White Plains: March of Dimes; 1987. p. 27–38.Google Scholar
  43. 43.
    Windebank AJ, Litchy WJ, Daube JR, Kurland LT, Codd MB, Iverson R. Late effects of paralytic poliomyelitis in Olmsted County, Minnesota. Neurology. 1991;41:501–7.PubMedCrossRefGoogle Scholar
  44. 44.
    Ivanyi B, Nollet F, Redekop WK, et al. Late onset polio sequelae: disabilities and handicaps in a population- based cohort of the 1956 poliomyelitis outbreak in The Netherlands. Arch Phys Med Rehabil. 1999;80:687–90.PubMedCrossRefGoogle Scholar
  45. 45.
    Ramlow J, Alexander M, LaPorte R, Kaufmann C, Kuller L. Epidemiology of the post-polio syndrome. Am J Epidemiol. 1992;136:769–86.PubMedCrossRefGoogle Scholar
  46. 46.
    Halstead LS. A brief history of postpolio syndrome in the United States. Arch Phys Med Rehabil. 2011;92:1344–9.PubMedCrossRefGoogle Scholar
  47. 47.
    Wiechers DO, Hubbell SL. Late changes in the motor unit after acute poliomyelitis. Muscle Nerve. 1981;4:524–8.PubMedCrossRefGoogle Scholar
  48. 48.
    Wiechers DO. New concepts of the reinnervated motor unit revealed by vaccine-associated poliomyelitis. Muscle Nerve. 1988;11:356–64.PubMedCrossRefGoogle Scholar
  49. 49.
    Cashman NR, Maselli R, Wollmann RL, Roos R, Simon R, Antel JP. Late denervation in patients with antecedent paralytic poliomyelitis. N Eng J Med. 1987;317:7–12.CrossRefGoogle Scholar
  50. 50.
    Trojan DA, Gendron D, Cashman NR. Electrophysiology and electrodiagnosis of the post-polio motor unit. Orthopedics. 1991;14:1353–61.PubMedGoogle Scholar
  51. 51.
    Trojan DA, Gendron D, Cashman NR. Anticholinesterase responsive neuromuscular junction transmission defects in post-poliomyelitis fatigue. J Neurol Sci. 1993;114:170–7.PubMedCrossRefGoogle Scholar
  52. 52.
    Trojan DA, Gendron D, Cashman NR. Stimulation frequency-dependent neuromuscular junction transmission defects in patients with prior paralytic poliomyelitis. J Neurol Sci. 1993;118:150–7.PubMedCrossRefGoogle Scholar
  53. 53.
    Stalberg E. Use of single fiber EMG and macro EMG in study of reinnervation. Muscle Nerve. 1990;13:804–13.PubMedCrossRefGoogle Scholar
  54. 54.
    Cashman NR, Trojan DA. Correlation of electrophysiology with pathology, pathogenesis and anticholinesterase therapy in post-­polio syndrome. Ann N Y Acad Sci. 1995;753:138–50.PubMedCrossRefGoogle Scholar
  55. 55.
    Trojan DA, Cashman NR, Shapiro S, Tansey C, Esdaile JM. Predictive factors for post-poliomyelitis syndrome. Arch Phys Med Rehabil. 1994;75:770–7.PubMedGoogle Scholar
  56. 56.
    McComas AJ, Quartly C, Griggs RC. Early and late losses of motor units after poliomyelitis. Brain. 1997;120:1415–21.PubMedCrossRefGoogle Scholar
  57. 57.
    Daube JR, Sorenson EJ, Windebank AJ. Prospective 15-year study of neuromuscular function in a cohort of patients with prior poliomyelitis. Clin Neurophysiol. 2009;60:s197–201.Google Scholar
  58. 58.
    Kaminski HJ, Tresser N, Hogan RE, Martin E. Spinal cord histopathology in long-term survivors of poliomyelitis. Muscle Nerve. 1995;18:1208–9.PubMedCrossRefGoogle Scholar
  59. 59.
    Dalakas MC. Pathogenetic mechanisms of post-polio syndrome: morphological, electrophysiological, virological, and immunological correlations. Ann N Y Acad Sci. 1995;753:167–85.PubMedCrossRefGoogle Scholar
  60. 60.
    Sharief MK, Hentges R, Ciardi M. Intrathecal immune response in patients with the post-polio syndrome. N Engl J Med. 1991;325:749–55.PubMedCrossRefGoogle Scholar
  61. 61.
    Melchers W, de Visser M, Jongen P, van Loon A, Nibbeling R, Oostvogel P, et al. The postpolio syndrome: no evidence for poliovirus persistence. Ann Neurol. 1992;32:728–32.PubMedCrossRefGoogle Scholar
  62. 62.
    Salazar-Grueso EF, Grimaldi LME, Roos RP, Variakojis R, Jubelt B, Cashman NR. Isoelectric focusing studies of serum and cerebrospinal fluid in patients with antecedent poliomyelitis. Ann Neurol. 1989;26:709–13.PubMedCrossRefGoogle Scholar
  63. 63.
    Berlly MH, Strauser WW, Hall KM. Fatigue in postpolio syndrome. Arch Phys Med Rehabil. 1991;72:115–8.PubMedGoogle Scholar
  64. 64.
    Tersteeg IM, Koopman FS, Stolwijk-Swaste JM, Beelen A, Nollet F. CARPA Study Group. A 5-year longitudinal study of fatigue in patients with late-onset sequelae of poliomyelitis. Arch Phys Med Rehabil. 2011;92:899–904.PubMedCrossRefGoogle Scholar
  65. 65.
    Trojan DA, Arnold DL, Shapiro S, et al. Fatigue in post-poliomyelitis syndrome: association with disease-related, behavioral, and psychosocial factors. PM R. 2009;1:442–9.PubMedCrossRefGoogle Scholar
  66. 66.
    Chaudhuri A, Behan PO. Fatigue in neurological disorders. Lancet. 2004;363:978–88.PubMedCrossRefGoogle Scholar
  67. 67.
    On AY, Oncu J, Atamaz F, Durmaz B. Impact of post-polio-related fatigue on quality of life. J Rehabil Med. 2006;38:329–32.PubMedCrossRefGoogle Scholar
  68. 68.
    Werhagen L, Borg K. Analysis of long-standing nociceptive and neuropathic pain in patients with post-polio syndrome. J Neurol. 2010;257:1027–31.PubMedCrossRefGoogle Scholar
  69. 69.
    Stoelb BL, Carter GT, Abresch RT, Purekal S, McDonald CM, Jensen MP. Pain in persons with postpolio syndrome: frequency, intensity, and impact. Arch Phys Med Rehabil. 2008;89:1933–40.PubMedCrossRefGoogle Scholar
  70. 70.
    Vasiliadis HM, Collet JP, Shapiro S, Venturini A, Trojan DA. Predictive factors and correlates for pain in postpoliomyelitis syndrome patients. Arch Phys Med Rehabil. 2002;83:1109–15.PubMedCrossRefGoogle Scholar
  71. 71.
    Trojan DA, Cashman NR. Fibromyalgia is common in a postpoliomyelitis clinic. Arch Neurol. 1995;52:620–4.PubMedCrossRefGoogle Scholar
  72. 72.
    Sonies BC, Dalakas MC. Dysphagia in patients with the post-polio syndrome. N Engl J Med. 1991;324:1162–7.PubMedCrossRefGoogle Scholar
  73. 73.
    Bach JR. Pulmonary dysfunction and its management in post polio patients. Neuro Rehabil. 1997;7:147–88.CrossRefGoogle Scholar
  74. 74.
    Tate DG, Forchheimer M, Kirsch N, Maynard F, Roller A. Prevalence and associated features of depression and psychological distress in polio survivors. Arch Phys Med Rehabil. 1993;74:1056–60.PubMedCrossRefGoogle Scholar
  75. 75.
    Post Polio Task Force. Post-polio syndrome update. New York: BioScience Communications; 1997.Google Scholar
  76. 76.
    March of Dimes. Post-polio syndrome: identifying best practices in diagnosis and care. White Plains: March of Dimes; 2001.Google Scholar
  77. 77.
    Waring WP, Davidoff G, Werner RA. Serum creatine kinase in the post-polio population. Am J Phys Med Rehabil. 1988;68:86–90.CrossRefGoogle Scholar
  78. 78.
    Waring WP, McLaurin TM. Correlation of creatine kinase and gait measurement in the postpolio population: a corrected version. Arch Phys Med Rehabil. 1992;73:447–50.PubMedGoogle Scholar
  79. 79.
    Bromberg MB, Waring WP. Neurologically normal patients with suspected postpoliomyelitis syndrome: electromyographic assessment of past denervation. Arch Phys Med Rehabil. 1991;72:493–7.PubMedGoogle Scholar
  80. 80.
    Gawne AC, Pham BT, Halstead LS. Electrodiagnostic findings in 108 consecutive patients referred to a post-polio clinic. The value of routine electrodiagnostic studies. Ann N Y Acad Sci. 1995;753:383–5.PubMedGoogle Scholar
  81. 81.
    Rodriquez AA, Agre JC, Harmon RL, Franke TM, Swiggum ER, Curt JT. Electromyographic and neuromuscular variables in post-polio subjects. Arch Phys Med Rehabil. 1995;76:989–93.PubMedCrossRefGoogle Scholar
  82. 82.
    Emeryk B, Rowinska-Marcinska K, Ryniewicz B, Hausmanowa-Petrusewicz I. Disintegration of the motor unit in post-polio syndrome. Part II. Electrophysiological findings in patients with post-polio syndrome. Electromyogr Clin Neurophysiol. 1990;30:451–8.PubMedGoogle Scholar
  83. 83.
    Dean E, Ross J, Road JD, Courtenay L, Madill KJ. Pulmonary function in individuals with a history of poliomyelitis. Chest. 1991;100:118–23.PubMedCrossRefGoogle Scholar
  84. 84.
    Bach JR, Alba AS. Pulmonary dysfunction and sleep disordered breathing as post-polio sequelae: evaluation and management. Orthopedics. 1991;14:1329–37.PubMedGoogle Scholar
  85. 85.
    Midgren B. Lung function and clinical outcome in postpolio patients: a prospective cohort study during 11 years. Eur Respir J. 1997;10:146–9.PubMedCrossRefGoogle Scholar
  86. 86.
    Soliman MG, Higgins SE, El-Kabir DR, Davidson AC, Williams AJ, Howard RS. Non-invasive assessment of respiratory muscle strength in patients with previous poliomyelitis. Respir Med. 2005;99:1217–22.PubMedCrossRefGoogle Scholar
  87. 87.
    Ulfberg J, Jonsson R, Ekeroth G. Sleep apnea syndrome among poliomyelitis survivors. Neurology. 1997;49:1189.PubMedCrossRefGoogle Scholar
  88. 88.
    Hsu AA, Staats BA. “Postpolio” sequelae and sleep-related ­disordered breathing. Mayo Clin Proc. 1998;73:216–24.PubMedCrossRefGoogle Scholar
  89. 89.
    Jones B, Buchholz DW, Ravich WJ, Donner MW. Swallowing dysfunction in the postpolio syndrome: a cinefluorographic study. AJR Am J Roentgenol. 1992;158:283–6.PubMedCrossRefGoogle Scholar
  90. 90.
    Driscoll BP, Gracco C, Coelho C, et al. Laryngeal function in postpolio patients. Laryngoscope. 1995;105:35–41.PubMedCrossRefGoogle Scholar
  91. 91.
    Soderholm S, Lehtinen A, Valtonen K, Ylinen A. Dysphagia and dysphonia among persons with post-polio syndrome – a challenge in neurorehabilitation. Acta Neurol Scand. 2010;122:343–9.PubMedGoogle Scholar
  92. 92.
    Peach PE, Olejnik S. Effect of treatment and noncompliance on post-polio sequelae. Orthopedics. 1991;14:1199–203.PubMedGoogle Scholar
  93. 93.
    Silver JK, Aiello DD. What internist need to know about postpolio syndrome. Cleve Clin J Med. 2002;69:704–12.PubMedCrossRefGoogle Scholar
  94. 94.
    Nollet F. Postpolio syndrome: unanswered questions regarding cause, course, risk factors and therapies. Lancet Neurol. 2010;9:561–3.PubMedCrossRefGoogle Scholar
  95. 95.
    Gonzalez H, Olsson T, Borg K. Management of postpolio syndrome. Lancet Neurol. 2010;9:634–42.PubMedCrossRefGoogle Scholar
  96. 96.
    Farbu E, Gilhus NE, Barnes MP, et al. EFNS guideline on diagnosis and management of post-polio syndrome: report of an EFNS task force. Eur J Neurol. 2006;13:795–801.PubMedCrossRefGoogle Scholar
  97. 97.
    Jubelt B. Post-polio syndrome. Curr Treat Options Neurol. 2004;6:87–93.PubMedCrossRefGoogle Scholar
  98. 98.
    Dean E, Ross J. Effect of modified aerobic training on movement energetics in polio survivors. Orthopedics. 1991;14:1243–6.PubMedGoogle Scholar
  99. 99.
    Jones DR, Speier J, Canine K, Owen R, Stull GA. Cardiorespiratory responses to aerobic training by patients with postpoliomyelitis sequelae. JAMA. 1989;261:3255–8.PubMedCrossRefGoogle Scholar
  100. 100.
    Kriz JL, Jones DR, Speier JL, Owen RR, Serfass RC. Cardiorespiratory responses to upper extremity aerobic training by postpolio subjects. Arch Phys Med Rehabil. 1992;73:49–54.PubMedGoogle Scholar
  101. 101.
    Prins JH, Hartung H, Merritt DJ, Blanq RJ, Goebert DA. Effect of aquatic exercise training in persons with poliomyelitis disability. Sports Med Train Rehabil. 1994;5:29–39.CrossRefGoogle Scholar
  102. 102.
    Oncu J, Durmaz B, Karapolat H. Short-term effects of aerobic exercise on functional capacity, fatigue, and quality of life in patients with post-polio syndrome. Clin Rehabil. 2009;23:155–63.PubMedCrossRefGoogle Scholar
  103. 103.
    Willen C, Sunnerhagen K, Grimby G. Dynamic water exercise in individuals with late poliomyelitis. Arch Phys Med Rehabil. 2001;82:66–72.PubMedCrossRefGoogle Scholar
  104. 104.
    Agre JC, Rodriguez AA, Franke TM. Strength, endurance, and work capacity after muscle strengthening exercise in postpolio subjects. Arch Phys Med Rehabil. 1997;78:681–6.PubMedCrossRefGoogle Scholar
  105. 105.
    Einarsson G. Muscle adaptation and disability in late poliomyelitis. Scand J Rehabil Med. 1991;25:s1–76.Google Scholar
  106. 106.
    Grimby G, Stålberg E. Dynamic changes in muscle structure and electrophysiology in late polio with aspects on muscular trainability. Scand J Rehabil Med. 1994;30:s33–44.Google Scholar
  107. 107.
    Chan KM, Amirjani N, Sumrain M, Clarke A, Strohschein FJ. Randomized controlled trial of strength training in post-polio patients. Muscle Nerve. 2003;27:332–8.PubMedCrossRefGoogle Scholar
  108. 108.
    Davidson AC, Auyeung V, Luff R, Holland M, Hodgkiss A, Weinman J. Prolonged benefit in post-polio syndrome from comprehensive rehabilitation: a pilot study. Disabil Rehabil. 2009;31:309–17.PubMedCrossRefGoogle Scholar
  109. 109.
    Tiffreau V, Rapin A, Serafi R, Percebois-Macadre L, Supper C, Jolly D, et al. Post-polio syndrome and rehabilitation. Ann Phys Rehabil Med. 2010;53:42–50.PubMedCrossRefGoogle Scholar
  110. 110.
    Waring WP, Maynard F, Grady W, Grady R, Boyles C. Influence of appropriate lower extremity orthotic management on ambulation, pain, and fatigue in a postpolio population. Arch Phys Med Rehabil. 1989;68:86–90.CrossRefGoogle Scholar
  111. 111.
    Brehm MA, Beelen A, Doorenbosch CA, Harlaar J, Nollet F. Effect of carbon-composite knee-ankle-foot orthoses on walking efficiency and gait in former polio patients. J Rehabil Med. 2007;39:651–7.PubMedCrossRefGoogle Scholar
  112. 112.
    Hachisuka K, Makino K, Wada F, Saeki S, Yoshimoto N. Oxygen consumption, oxygen cost and physiological cost index in polio survivors: a comparison of walking without orthosis, with an ­ordinary or a carbon-fibre reinforced plastic knee-ankle-foot orthosis. J Rehabil Med. 2007;39:646–50.PubMedCrossRefGoogle Scholar
  113. 113.
    Clark DR, Perry J, Lunsford TR. Case studies – orthotic management of the adult post polio patient. Orthot Prosthet. 1986;40:43–50.Google Scholar
  114. 114.
    Kelley C, DiBello TV. Orthotic assessment for individuals with postpolio syndrome: a classification system. J Prosthet Orthot. 2007;19:109–13.CrossRefGoogle Scholar
  115. 115.
    Trojan DA, Finch L. Management of post-polio syndrome. NeuroRehabilitation. 1997;8:93–105.CrossRefGoogle Scholar
  116. 116.
    Borg GV. Perceived exertion as an indicator of somatic stress. Scand J Rehabil Med. 1970;21:82–98.Google Scholar
  117. 117.
    Willen C, Grimby G. Pain, physical activity, and disability in individuals with late effects of polio. Arch Phys Med Rehabil. 1998;79:915–9.PubMedCrossRefGoogle Scholar
  118. 118.
    Werner RA, Waring W, Maynard F. Osteoarthritis of the hand and wrist in the post poliomyelitis population. Arch Phys Med Rehabil. 1992;73:1069–72.PubMedGoogle Scholar
  119. 119.
    Werner RA, Waring WP, Davidoff G. Risk factors for median mononeuropathy of the wrist in postpoliomyelitis patients. Arch Phys Med Rehabil. 1989;70:464–7.PubMedCrossRefGoogle Scholar
  120. 120.
    Bach JR. Management of post-polio respiratory sequelae. Ann N Y Acad Sci. 1995;753:96–102.PubMedCrossRefGoogle Scholar
  121. 121.
    Markstrom A, Sundell K, Lysdahl M, Andersson G, Schedin U, Klang B. Quality-of-life evaluation of patients with neuromuscular and skeletal diseases treated with noninvasive and invasive home mechanical ventilation. Chest. 2002;122:1695–700.PubMedCrossRefGoogle Scholar
  122. 122.
    Barle H, Soderberg P, Haegerstrand C, Markstrom A. Bi-level positive airway pressure ventilation reduces the oxygen cost of breathing in long-standing post-polio patients on invasive home mechanical ventilation. Acta Anaesthesiol Scand. 2005;49:197–202.PubMedCrossRefGoogle Scholar
  123. 123.
    Buchholz DW, Jones B. Post-polio dysphagia: alarm or caution? Orthopedics. 1991;14:1303–5.PubMedGoogle Scholar
  124. 124.
    Sonies BC, Dalakas MC. Progression of oral-motor and swallowing symptoms in the post-polio syndrome. Ann N Y Acad Sci. 1995;753:87–95.PubMedCrossRefGoogle Scholar
  125. 125.
    Gawne AC, Halstead LS. Post-polio syndrome: pathophysiology and clinical management. Crit Rev Phys Rehabil Med. 1995;7:147–88.Google Scholar
  126. 126.
    Bruno RL, Frick NM. The psychology of polio as prelude to post-polio sequelae: behavior modification and psychotherapy. Orthopedics. 1991;14:1185–93.PubMedGoogle Scholar
  127. 127.
    Farbu E, Gilhus NE. Poliomyelitis: long-term consequences for social life. Acta Neurol Scand. 1997;96:353–8.PubMedCrossRefGoogle Scholar
  128. 128.
    Kemp BJ, Adams BM, Campbell ML. Depression and life satisfaction in aging polio survivors versus age- matched controls: relation to postpolio syndrome, family functioning, and attitude toward disability. Arch Phys Med Rehabil. 1997;78:187–92.PubMedCrossRefGoogle Scholar
  129. 129.
    Clark K, Dinsmore S, Grafman J, Dalakas MC. A personality profile of patients diagnosed with post-polio syndrome. Neurology. 1994;44:1809–11.PubMedCrossRefGoogle Scholar
  130. 130.
    Hazendonk KM, Crowe SF. A neuropsychological study of the postpolio syndrome: support for depression without neuropsychological impairment. Neuropsychiatry Neuropsychol Behav Neurol. 2000;13:112–8.PubMedGoogle Scholar
  131. 131.
    Klein MG, Whyte J, Esquenazi A, Keenan MA, Costello R. A comparison of the effects of exercise and lifestyle modification on the resolution of overuse symptoms of the shoulder in polio survivors: a preliminary study. Arch Phys Med Rehabil. 2002;83:708–13.PubMedCrossRefGoogle Scholar
  132. 132.
    Rekand T, Korv J, Farbu E, et al. Lifestyle and late effects after poliomyelitis: a risk factor study of two populations. Acta Neurol Scand. 2004;109:120–5.PubMedCrossRefGoogle Scholar
  133. 133.
    Elrod LM, Jabben M, Oswald G, Szirony GM. Vocational implications of post-polio syndrome. Work. 2005;25:155–61.PubMedGoogle Scholar
  134. 134.
    Koopman FS, Uegaki K, Gilhus NE, Beelen A, de Visser M, Nollet F. Treatment for postpolio syndrome. Cochrane Database Syst Rev. 2011:CD007818.Google Scholar
  135. 135.
    Chan KM, Strohschein FJ, Rydz D, Allidina A, Shuaib A, Westbury CF. Randomized controlled trial of modafinil for the treatment of fatigue in postpolio patients. Muscle Nerve. 2006;33:138–41.PubMedCrossRefGoogle Scholar
  136. 136.
    Vasconcelos OM, Prokhorenko OA, Salajegheh MK, Kelley KF, Livornese K, Olsen CH, et al. Modafinil for treatment of fatigue in post-polio syndrome: a randomized controlled trial. Neurology. 2007;68:1680–6.PubMedCrossRefGoogle Scholar
  137. 137.
    Trojan DA, Collet JP, Shapiro S, Jubelt B, Miller RG, Agre JC, et al. A multicenter, randomized, double-blinded trial of pyridostigmine in postpolio syndrome. Neurology. 1999;53:1225–33.PubMedCrossRefGoogle Scholar
  138. 138.
    Horemans HL, Nollet F, Beelen A, Drost G, Stegeman DF, Zwarts MJ, et al. Pyridostigmine in postpolio syndrome: no decline in fatigue and limited functional improvement. J Neurol Neurosurg Psychiatry. 2003;74:1655–61.PubMedCrossRefGoogle Scholar
  139. 139.
    On AY, Oncu J, Uludag B, Ertekin C. Effects of lamotrigine on the symptoms and life qualities of patients with post polio syndrome: a randomized, controlled study. NeuroRehabilitation. 2005;20:245–51.PubMedGoogle Scholar
  140. 140.
    Dinsmore S, Dambrosia J, Dalakas MC. A double-blind, placebo-controlled trial of high-dose prednisone for the treatment of post-poliomyelitis syndrome. Ann N Y Acad Sci. 1995;753:303–13.PubMedCrossRefGoogle Scholar
  141. 141.
    Stein DP, Dambrosia JM, Dalakas MC. A double-blind, placebo-controlled trial of amantadine for the treatment of fatigue in patients with the post-polio syndrome. Ann N Y Acad Sci. 1995;753:296–302.PubMedCrossRefGoogle Scholar
  142. 142.
    Gonzalez H, Sunnerhagen KS, Sjöberg I, Kaponides G, Olsson T, Borg K. Intravenous immunoglobulin for postpolio syndrome: a randomised controlled trial. Lancet Neurol. 2006;5:493–500.PubMedCrossRefGoogle Scholar
  143. 143.
    Farbu E, Rekand T, Vik-Mo E, Lygren H, Gilhus NE, Aarli JA. Post-polio syndrome patients treated with intravenous immunoglobulin: a double-blinded randomized controlled pilot study. Eur J Neurol. 2007;14:60–5.PubMedCrossRefGoogle Scholar
  144. 144.
    Miller RG, Gelinas DF, Kent-Braun J, Dobbins T, Dao H, Dalakas M. The effect of recombinant insulin-like growth factor I (rhIGF-I) on exercise-induced fatigue and recovery in patients with post-polio syndrome. Neurology. 1997;48:A217.Google Scholar
  145. 145.
    Gupta KL, Shetty KR, Agre JC, Cuisinier MC, Rudman IW, Rudman D. Human growth hormone effect on serum IGF-I and muscle function in poliomyelitis survivors. Arch Phys Med Rehabil. 1994;75:889–94.PubMedCrossRefGoogle Scholar
  146. 146.
    Bruno RL. Post-polio syndrome. Neurology. 1996;47:1359–60.PubMedCrossRefGoogle Scholar
  147. 147.
    Bruno RL, Zimmerman JR, Creange SJ, Lewis T, Molzen T, Frick NM. Bromocriptine in the treatment of post-polio fatigue: a pilot study with implications for the pathophysiology of fatigue. Am J Phys Med Rehabil. 1996;75:340–7.PubMedCrossRefGoogle Scholar
  148. 148.
    Skough K, Krossen C, Heiwe S, Theorell H, Borg K. Effects of resistance training in combination with coenzyme Q10 supplementation in patients with post-polio: a pilot study. J Rehabil Med. 2008;40:773–5.PubMedCrossRefGoogle Scholar
  149. 149.
    Haziza M, Kremer R, Benedetti A, Trojan DA. Osteoporosis in a postpolio clinic population. Arch Phys Med Rehabil. 2007;88:1030–5.PubMedCrossRefGoogle Scholar
  150. 150.
    Mohammad AF, Khan KA, Galvin L, Hardiman O, O’Connell PG. High incidence of osteoporosis and fractures in an aging post-polio population. Eur Neurol. 2009;62:369–74.PubMedCrossRefGoogle Scholar
  151. 151.
    Silver JK, Aiello DD. Polio survivors: falls and subsequent injuries. Am J Phys Med Rehabil. 2002;81:567–70.PubMedCrossRefGoogle Scholar
  152. 152.
    Alvarez A, Kremer R, Weiss DR, Benedetti A, Haziza M, Trojan DA. Response of postpoliomyelitis patients to bisphosphonate treatment. PM R. 2010;2:1094–103.PubMedCrossRefGoogle Scholar
  153. 153.
    Grimby G, Hedberg M, Henning GB. Changes in muscle morphology, strength and enzymes in a 4–5 year follow-up of subjects with poliomyelitis sequelae. Scand J Rehabil Med. 1994;26:121–30.PubMedGoogle Scholar
  154. 154.
    Agre JC, Grimby G, Rodriquez AA, Einarsson G, Swiggum ER, Franke TM. A comparison of symptoms between Swedish and American post-polio individuals and assessment of lower limb strength – a four-year cohort study. Scand J Rehabil Med. 1995;27:183–92.PubMedGoogle Scholar
  155. 155.
    Sorenson EJ, Daube JR, Windebank AJ. A 15-year follow-up of neuromuscular function in patients with prior poliomyelitis. Neurology. 2005;64:1070–2.PubMedCrossRefGoogle Scholar
  156. 156.
    Munin MC, Jaweed MM, Staas Jr WE, Satinsky AR, Gutlerez G, Herbison GJ. Postpoliomyelitis muscle weakess: a prospective study of quadriceps strength. Arch Phys Med Rehabil. 1991;72:729–33.PubMedGoogle Scholar
  157. 157.
    Stolwijk-Swüste JM, Beelen A, Lankhorst GJ, Nollet F, CARPA Study Group. The course of functional status and muscle strength in patients with late-onset sequelae of poliomyelitis: a systematic review. Arch Phys Med Rehabil. 2005;86:1693–701.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  1. 1.Division of Neurology, Department of Internal Medicine, Faculty of Medicine, Siriraj HospitalMahidol UniversityBangkokThailand

Personalised recommendations